Activated Partial Thromboplastin Time (APTT / PTTK)
Report Delivery Time: Same Day
Recommended Gender: Both
Sample Type: Blood
The Activated Partial Thromboplastin Time (APTT / PTTK) test measures how long it takes for blood to clot, helping assess bleeding disorders, clotting factor deficiencies, and the effectiveness of anticoagulant therapy.
₹500.00
+919354028488
Email Address
info@hprimelabs.com
Email Address
customercare@hprimelabs.com
Related Packages
Advanced Full Body Checkup for Females
Report Delivery: 12 hours
Parameters: 14
Gender: Both
Sample: Blood, Urine
Immunity Health Checkup
Report Delivery: 12 hours
Parameters: 16
Gender: Both
Sample: Blood
Related Tets
AFP (Alpha Feto Protein)
Report Delivery: Same Day
Parameters: 1
Gender: Both
Sample: Blood
The Alpha-Fetoprotein (AFP) test measures AFP levels in the blood and is primarily used for screening liver cancer (hepatocellular carcinoma), germ cell tumors, and monitoring fetal development during pregnancy.
Amylase (Serum)
Report Delivery: Same Day
Parameters: 1
Gender: Both
Sample: Blood
The Amylase (Serum) test measures the level of amylase enzyme in the blood and is primarily used to diagnose and monitor pancreatitis, pancreatic disorders, and other digestive system conditions.
The Activated Partial Thromboplastin Time (APTT / PTTK) test is a clotting test used to evaluate the blood’s ability to form clots properly. It is particularly useful in diagnosing bleeding disorders, clotting factor deficiencies, and monitoring heparin therapy in patients undergoing anticoagulant treatment. This test assesses the function of the intrinsic and common pathways of the coagulation cascade by measuring the time it takes for a clot to form in a plasma sample mixed with reagents. Prolonged APTT results may indicate conditions such as hemophilia, liver disease, vitamin K deficiency, or the presence of lupus anticoagulants.
What’s Included in This Test?
- Measurement of clotting time (APTT/PTTK value)
- Evaluation of intrinsic and common coagulation pathways
- Detection of clotting factor deficiencies (e.g., Hemophilia A & B)
- Monitoring of anticoagulant (heparin) therapy
Recommended Gender:
✅ Suitable for both men and women
Test Details:
- Sample Type: Plasma (Citrated, 1mL)
- Method: Clotting
